Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection.

Stellini, Roberto; Gianello, Renzo; Meloni, Angelo; Croce, Elia; Materzanini, Paola; Gomarasca, Walter

Stellini, Roberto; Gianello, Renzo; Meloni, Angelo; Croce, Elia; Materzanini, Paola; Gomarasca, Walter.

Afiliación

Stellini R; Infectious Diseases Service, Health Care Department, Poliambulanza Foundation Hospital, Brescia, Italy. roberto.stellini@poliambulanza.it.
Gianello R; Department of Clinical Laboratory, Poliambulanza Foundation Hospital, Brescia, Italy.
Meloni A; Department of Clinical Laboratory, Poliambulanza Foundation Hospital, Brescia, Italy.
Croce E; Health Care Department, Poliambulanza Foundation Hospital, Brescia, Italy.
Materzanini P; Health Care Department, Poliambulanza Foundation Hospital, Brescia, Italy.
Gomarasca W; Department of Occupational Medicine, Poliambulanza Foundation Hospital, Brescia, Italy.

Infection ; 50(3): 791-793, 2022 06.

Article en En | MEDLINE | ID: mdl-34855188

Asunto(s)

COVID-19; Vacunas; COVID-19/prevención & control; Vacunas contra la COVID-19/efectos adversos; Humanos; SARS-CoV-2; Vacunas Sintéticas; Vacunas de ARNm

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Humans Idioma: En Revista: Infection Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google